CANNASIGNAL™
LIVE DATA
🔍
SIGNAL
HEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition buildingHEMP BAN: Federal intoxicating-hemp ban takes effect Dec 11, 2026 — consumer migration to licensed markets expectedFEDERAL: Schedule III rescheduling in progress — 280E relief expected late 2026FEDERAL RISK INDEX: 37/100 (LOW) — rescheduling momentum growingVA: Adult-use retail launches Jul 1, 2027 — license applications open Feb 1, 2027IL: SB 3222 omnibus signed — possession limits doubled, intoxicating hemp moves to dispensaries Nov 12MI: 24% wholesale tax challenged in court — repeal bill SB 810 pending in committeeCA: Cannabis excise tax locked at 15% through July 2028 per AB 564NJ: Cannabis consumption lounges now open in Atlantic City, Newark, MerchantvilleMN: Omnibus Cannabis Act signed — hemp-to-cannabis license bridge ahead of federal banOK: Governor pushes to eliminate medical program — bipartisan opposition building
NY S01137Introducedas of 2025-01-08

Increases the amount of funding permissible for the investment in a cannabis private debt or equity fund to $300,000,000.

Plain-English summary

What happened: A New York bill referred to the Finance committee would raise the permissible investment cap in a cannabis private debt or equity fund to $300,000,000.

Why it matters: A higher investment ceiling could expand access to capital for cannabis businesses operating in New York's regulated market.

Affects: retailers and cultivators and labs

LATEST ACTION: REFERRED TO FINANCE
READ THE FULL BILL TEXT →
Follow New York cannabis bills for free. One plain-English email a week with every bill that moved, including this one.
Get the free digest
More New York cannabis bills
S10643Relates to labor peace agreements and the cannabis industry wage board.PassedS10113Provides that a microbusiness licensee authorized to conduct retail sales may serve as a processor and cultivator for purposes of cannabis showcase event permits.PassedA11606Prohibits cannabis products, or packaging or labeling for a cannabis product, that are substantially similar to or likely to create confusion with a non-cannabis product.IntroducedS00845Prohibits drug, cannabis or alcohol testing of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing is necessary for a medical emergency.In CommitteeA10698Enacts the "cannabis supply chain integrity and anti-inversion act"; prohibits any act or omission involving illicit cannabis; provides penalties for such cannabis inversion.In CommitteeA11562Relates to labor peace agreements and the cannabis industry wage board.IntroducedS10347Requires prospective licensees of cannabis licenses to submit a formal attestation of compliance with local zoning laws, land-use regulations, and municipal code requirements and proof of local municipal compliance to the Cannabis Control Board when applying for an OCM Cannabis license, and give municipalities the ability to request an extension of time to submit an opinion on the prospective licensee application.IntroducedA11217Provides that a microbusiness licensee authorized to conduct retail sales may serve as a processor and cultivator for purposes of cannabis showcase event permits.Introduced
ALL NEW YORKCANNABIS LAWS & BILLS →

Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.